News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,855 Results
Type
Article (42550)
Company Profile (295)
Press Release (677010)
Multimedia
Podcasts (81)
Webinars (12)
Section
Business (210481)
Career Advice (2096)
Deals (36635)
Drug Delivery (107)
Drug Development (83067)
Employer Resources (175)
FDA (16588)
Job Trends (15417)
News (356128)
Policy (33935)
Tag
Academia (2598)
Accelerated approval (5)
Adcomms (21)
Allergies (92)
Alliances (51451)
ALS (99)
Alzheimer's disease (1405)
Antibody-drug conjugate (ADC) (140)
Approvals (16583)
Artificial intelligence (281)
Autoimmune disease (24)
Automation (17)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (189)
Bladder cancer (79)
Brain cancer (29)
Breast cancer (295)
Cancer (2362)
Cardiovascular disease (188)
Career advice (1756)
Career pathing (31)
CAR-T (158)
Cell therapy (447)
Cervical cancer (20)
Clinical research (67653)
Collaboration (882)
Company closure (2)
Compensation (576)
Complete response letters (25)
COVID-19 (2663)
CRISPR (47)
C-suite (259)
Cystic fibrosis (106)
Data (2353)
Decentralized trials (2)
Denatured (29)
Depression (47)
Diabetes (279)
Diagnostics (6467)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (119)
Drug shortages (28)
Duchenne muscular dystrophy (98)
Earnings (88781)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (115567)
Executive appointments (763)
FDA (17990)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (785)
Gene editing (116)
Generative AI (22)
Gene therapy (332)
GLP-1 (760)
Government (4557)
Grass and pollen (5)
Guidances (162)
Healthcare (19004)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (136)
Indications (30)
Infectious disease (2809)
Inflammatory bowel disease (147)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (100)
Interviews (324)
IPO (16808)
IRA (47)
Job creations (4060)
Job search strategy (1495)
Kidney cancer (10)
Labor market (43)
Layoffs (500)
Leadership (18)
Legal (8380)
Liver cancer (77)
Lung cancer (327)
Lymphoma (159)
Machine learning (9)
Management (59)
Manufacturing (345)
MASH (79)
Medical device (13471)
Medtech (13476)
Mergers & acquisitions (20400)
Metabolic disorders (732)
Multiple sclerosis (83)
NASH (17)
Neurodegenerative disease (99)
Neuropsychiatric disorders (29)
Neuroscience (1986)
NextGen: Class of 2025 (6637)
Non-profit (4528)
Now hiring (40)
Obesity (386)
Opinion (230)
Ovarian cancer (82)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (156)
Partnered (22)
Patents (251)
Patient recruitment (117)
Peanut (49)
People (59341)
Pharmaceutical (91)
Pharmacy benefit managers (22)
Phase I (20987)
Phase II (29773)
Phase III (22299)
Pipeline (1399)
Policy (161)
Postmarket research (2654)
Preclinical (8949)
Press Release (68)
Prostate cancer (109)
Psychedelics (31)
Radiopharmaceuticals (252)
Rare diseases (405)
Real estate (6258)
Recruiting (67)
Regulatory (23197)
Reports (48)
Research institute (2370)
Resumes & cover letters (358)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (80)
Series A (135)
Series B (92)
Service/supplier (12)
Sickle cell disease (55)
Special edition (17)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3730)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (56)
The Weekly (50)
Vaccines (720)
Venture capitalists (42)
Weight loss (256)
Women's health (36)
Worklife (16)
Date
Today (143)
Last 7 days (1000)
Last 30 days (3286)
Last 365 days (33003)
2025 (12178)
2024 (35773)
2023 (40631)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33139)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27631)
2012 (29731)
2011 (30488)
2010 (28500)
Location
Africa (781)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (40774)
Australia (6531)
California (6474)
Canada (2085)
China (556)
Colorado (277)
Connecticut (282)
Delaware (162)
Europe (87132)
Florida (962)
Georgia (216)
Idaho (57)
Illinois (561)
India (26)
Indiana (332)
Iowa (11)
Japan (177)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (932)
Massachusetts (4850)
Michigan (228)
Minnesota (407)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1816)
New Mexico (29)
New York (1824)
North Carolina (1013)
North Dakota (8)
Northern California (2853)
Ohio (210)
Oklahoma (14)
Oregon (39)
Pennsylvania (1441)
Puerto Rico (13)
Rhode Island (33)
South America (1163)
South Carolina (26)
South Dakota (1)
Southern California (2428)
Tennessee (106)
Texas (965)
United States (24347)
Utah (190)
Virginia (162)
Washington D.C. (64)
Washington State (575)
West Virginia (3)
Wisconsin (60)
719,855 Results for "portola pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025
March 24, 2025
·
6 min read
Press Releases
Kezar Life Sciences Announces Positive Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis (AIH) and Reports Fourth Quarter and Year End 2024 Financial Results
March 26, 2025
·
15 min read
Press Releases
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
May 12, 2025
·
5 min read
Press Releases
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
May 8, 2025
·
5 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Drug Development
Kezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE Update
October 17, 2024
·
5 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025
May 7, 2025
·
5 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025
May 12, 2025
·
4 min read
1 of 71,986
Next
